Increased miR-142 and decreased DJ-1 enhance the sensitivity of pancreatic cancer cell to adriamycin
G.-Y. Han, J.-H. Cui, S. Liang, H.-L. Li Second Department of General Surgery, Hongqi Hospital Affiliated to Mudanjiang Medical University, Mudanjiang, China.
Since this article has been suspected of research misconduct and the corresponding authors did not respond to our request to prove originality of data and figures, “Increased miR-142 and decreased DJ-1 enhance the sensitivity of pancreatic cancer cell to adriamycin, by G.-Y. Han, J.-H. Cui, S. Liang, H.-L. Li, published in Eur Rev Med Pharmacol Sci 2018; 22 (22): 7696-7703–DOI: 10.26355/eurrev_201811_16390–PMID: 30536312” has been withdrawn.
The Publisher apologizes for any inconvenience this may cause.
Free PDF DownloadIncreased miR-142 and decreased DJ-1 enhance the sensitivity of pancreatic cancer cell to adriamycin
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
To cite this article
G.-Y. Han, J.-H. Cui, S. Liang, H.-L. Li
Increased miR-142 and decreased DJ-1 enhance the sensitivity of pancreatic cancer cell to adriamycin
Eur Rev Med Pharmacol Sci
Year: 2020
Vol. 24 - N. 22
Pages: 11464-11464
DOI: 10.26355/eurrev_202011_23751